
Moleculin Announces World Health Organization Approval of “naxtarubicin” as International Non-Proprietary Name for ...
Annamycin has the potential to be safer and more effective than current prescribed anthracyclines to treat serious, hard-to-treat cancers Ongoing pivotal, adaptive Phase 3 clinical trial (the “MIRACLE” trial) evaluating Annamycin for the treatment of acute …